Illness	Number of cases
Left ventricular failure unspecified (I50.14)	184
Essential primary hypertension (I10.01)	120
Other and unspecified infectious diseases (B99)	91
Syncope and collapse (R55)	80
Chronic obstructive pulmonary disease with acute exacerbation (J44.19)	79
Volume depletion (E86)	75
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	59
Lymphedema not elsewhere classified (I89.02)	58
Dizziness and giddiness (R42)	48
Mental and behavioural disorders due to use of alcohol (F10.0)	45

Top 10 treatments

Treatment	Number
Computed tomography (CT) of the head without contrast medium (3-200)	575
(9-984.7)	466
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	402
Computed tomography of the chest with contrast medium (3-222)	401
Radio-controlled cardiological telemetry (8-933)	364
(9-984.8)	355
Computed tomography of the abdomen with contrast medium (3-225)	346
Computed tomography of the pelvis with contrast medium (3-226)	317
(9-984.b)	265
Interdisciplinary measures for early postoperative treatment and early rehabilitation of ill elderly people (8-550.1)	228

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
16	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
2	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility